Nanoplatin (NC-6004)

NC-6004 · NanoCarrier Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nanoplatin (NC-6004), covering 2014-01-09 to 2014-01-09. Get the full timeline:

Most recent: Clinical Trial Update: NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia [Phase 1, Phase 2]